- High gross margin of 98.3%
- +86.7% price growth over the last year
- Highly efficient cash conversion (123% FCF/OCF ratio)
Green day on Friday for Enanta Pharmaceuticals stock after gaining 4.09%
(Updated on Jun 26, 2026)
The Enanta Pharmaceuticals stock price gained 4.09% on the last trading day (Friday, 26th Jun 2026), rising from $13.45 to $14.00. During the last trading day the stock fluctuated 6.11% from a day low at $13.43 to a day high of $14.25. The price has risen in 7 of the last 10 days and is up by 21.63% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 757 thousand more shares were traded than the day before. In total, 938 thousand shares were bought and sold for approximately $13.13 million.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $14.80 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -8.01% during the next 3 months and, with a 90% probability hold a price between $9.93 and $13.61 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
ENTA Signals & Forecast
The Enanta Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $13.41 and $13.06. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 23, 2026, and so far it has fallen -0.427%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Enanta Pharmaceuticals stock
Enanta Pharmaceuticals finds support from accumulated volume at $13.53 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.82 between high and low, or 6.11%. For the last week, the stock has had daily average volatility of 7.06%.
Our recommended stop-loss: $13.49 (-3.67%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 3 days ago.)
Trading Expectations (ENTA) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect Enanta Pharmaceuticals to open at $13.89, and during the day (based on 14 day Average True Range), to move between $13.59 and $14.41, which gives a possible trading interval of +/-$0.81 (+/-5.98%) up or down from last closing price. If Enanta Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 5.98% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $14.06 (0.43%) than the support at $13.53 (3.36%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Enanta Pharmaceuticals stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.
Current score:
2.540
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 29, 2026 - $13.89 ( 0.762%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ENTA Performance
Trading levels for ENTA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 14.71 | 5.10% |
| R2 | 14.40 | 2.86% |
| R1 | 14.21 | 1.48% |
| Price | 14.00 | |
| S1 | 13.58 | -3.00% |
| S2 | 13.39 | -4.38% |
| S3 | 13.07 | -6.62% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 15.24 | 8.86% |
| R2 | 14.53 | 3.79% |
| R1 | 14.06 | 0.429% |
| Price | 14.00 | |
| S1 | 13.53 | -3.36% |
| S2 | 13.45 | -3.93% |
| S3 | 11.24 | -19.71% |
FAQ
Click here for our free guide on how to buy Enanta Pharmaceuticals Stock.
Buy ENTA